Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
COMPLETED
NCT05556967
PHASE3

Identification of Surrogate Blood and/or Urine Biomarker for Immulina TM (Trademark) in Normal Humans

Sponsor: University of Mississippi Medical Center

View on ClinicalTrials.gov

Summary

This is a pilot study for identifying plasma and/or urine-derived adherence/surrogate biomarker candidates for verifying Immulina™ ingestion by human volunteers (collected before and after consumption of Immulina™, a natural dietary supplement).

Official title: Identification of Surrogate Blood and/or Urine Biomarker for Immulina TM in Normal Humans

Key Details

Gender

All

Age Range

18 Years - 50 Years

Study Type

INTERVENTIONAL

Enrollment

20

Start Date

2023-08-09

Completion Date

2023-10-19

Last Updated

2026-07-30

Healthy Volunteers

Yes

Interventions

DRUG

Immulina

Immulina is a highly standardized extract derived from various preparations of Spirulina, a cyanobacterium, marketed as a dietary supplement and has been utilized in several clinical studies describing its immunopotentiating properties.

Locations (1)

Clinical Research and Trials Unit - University of Mississippi Medical Center

Jackson, Mississippi, United States